Top 10 stocks to buy: Looking for investment ideas for your portfolio for the long term? Even in a volatile market, there is an opportunity to invest in good quality shares in the portfolio with a long-term perspective. Here’s a list of 10 stocks that brokerages such as SBI Securities, Sharekhan and are bullish on from a long-term perspective. Analysts see upside potential of as high as 21 per cent in these stocks. Do you have any of these in your portfolio?

Minda Corp 

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

SBI Securities has a ‘buy’ call on Minda Corporation shares with a price target of Rs 382. As of September 29, the brokerage’s target implies an upside of almost 15 per cent in the stock of the auto component manufacturer.

Gabriel India 

Sharekhan has a ‘buy’ rating on Gabriel India shares with a price target of Rs 384. The brokerage’s target implies an upside of more than 16 per cent in the auto parts maker’s stock.

Kirloskar Oil Engines 

Sharekhan has a ‘buy’ rating on Kirloskar Oil Engines, a manufacturer of engines, generating sets, pump sets, power tillers and related spares. Its price target of Rs 621 suggests an upside of nearly 15 per cent in the stock, as of September 29.

Greenpanel Industries 

HDFC Securities has a ‘buy’ rating on interior infrastructure company Greenpanel Industries’ shares with a target of Rs 450, which suggests an upside of more than 18 per cent.

DCB Bank 

BOB Capital Markets has a 'buy' call on DCB Bank shares with a target of Rs 144.

Marico share 

Sharekhan recommends going long on Marico shares for a target of Rs 645. As of September 29, the target implies an upside of 15 per cent in the FMCG stock.

Global Health 

Motilal Oswal suggests buying shares in the Medanta hospital chain operator Global Health for a target of Rs 840.

PI Industries 

Geojit Financial Services has a ‘buy’ call on agrochemicals manufacturer PI Industries with a price target of Rs 4,000.

Kajaria Ceramics

Sharekhan has a ‘buy’ rating on tiles manufacturer Kajaria Ceramics with a target price of Rs 1,600. The brokerage’s target implies an upside to the tune of 21 per cent in the stock, as of September 29.

Sun Pharma

Sharekhan has a ‘buy’ rating on Sun Pharma shares with a target of Rs 1,300.

(Disclaimer: The stock recommendations given here are by brokerage(s). These are not the views of Zee Business. Consult a professional advisor before making an investment decision.)

For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com.